China said Tuesday that it is now requiring permits for exports to the United States, Mexico and Canada of two additional ...

The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing ...

Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next ...

Finding innovative ways to treat cancer is Pfizer’s biggest priority so to boost cutting-edge technologies, Pfizer executives went to Shenyang, China. There, last summer, Pfizer paid $1.25 billion to ...

But Congress should reject any effort to codify “Most Favored Nation” drug pricing—whether as a broad mandate, a limited ...

The next breakthrough therapy may still be marketed in New York or Basel. But increasingly, it is being born in Shanghai. China’s pharmaceutical industry has moved beyond imitation into something more ...

SHANGHAI, July 23 (Reuters) - Hong Kong-listed Insilico Medicine (3696.HK), opens new tab has cut drug development timelines to about one year by combining AI with its China research ecosystem, its ...

If you’re a law enforcement agency trying to warn the public about the harms of recreational drug use, the last thing you should do is make a music video glamorizing drug use. On Friday—the ...

SHANGHAI, June 29 (Reuters) - GLP-1 drugs from Pfizer (PFE.N), opens new tab and Innovent Biologics (1801.HK), opens new tab have passed a preliminary review to be potentially included in China's ...